Nitrosamine Impurities Affecting Drug-Drug Interaction Studies – Learn More

Thank you for visiting us at DIA 2024

Enter for your chance to win a reMarkable Tablet.

Please find below some of our latest resources that highlight our experience and expertise as a full service early phase CRO.
Don’t forget to complete the entry form for your chance to win a reMarkable Tablet.

Enter Giveaway

Fact Sheet

Celerion Overview

Learn More

Fact Sheet

Product Labeling Studies

Learn More

Fact Sheet

Lincoln Overview

Learn More

Fact Sheet

Leverage Our Regulatory Experts for Pre-IND and IND Support

Learn More

Fact Sheet

Biomarker Excellence

Learn More

Fact Sheet

Phoenix Overview

Learn More

Article

The Impact of N-nitrosamine Impurities on Clinical Drug Development

Learn More

Article

Prevalence of Baseline Cardiac Arrhythmias

Learn More

Whitepaper

Refining Transporter DDI Studies with Endogenous Biomarkers

Learn More

Scientific Poster

What to Expect from a Phenytoin Drug-Drug Interaction Study

Learn More

Fact Sheet

ADME Studies and Radiolabeled Capabilities

Learn More

Fact Sheet

Leverage Our Renal/Hepatic PK Study Experience & Expertise

Learn More
remarkable tablet

Enter to win a reMarkable Tablet.

For additional marketing literature and thought leadership content please visit our Resource Center.

Contact

Ready to Get Started?

Contact Celerion to learn more. 

Contact Us